Abstract:Abstract Combining multiple types of genomic, transcriptional, proteomic, and epigenetic datasets has the potential to reveal biological mechanisms across multiple scales, and may lead to more accurate models for clinical decision support. Developing efficient models that can derive clinical outcomes from high-dimensional data remains problematical; challenges include the integration of multiple types of omics data, inclusion of biological background knowledge, and developing machine learning models that are able to deal with this high dimensionality while having only few samples from which to derive a model. We developed DeepMOCCA, a framework for multi-omics cancer analysis. We combine different types of omics data using biological relations between genes, transcripts, and proteins, combine the multi-omics data with background knowledge in the form of protein–protein interaction networks, and use graph convolution neural networks to exploit this combination of multi-omics data and background knowledge. DeepMOCCA predicts survival time for individual patient samples for 33 cancer types and outperforms most existing survival prediction methods. Moreover, DeepMOCCA includes a graph attention mechanism which prioritizes driver genes and prognostic markers in a patient-specific manner; the attention mechanism can be used to identify drivers and prognostic markers within cohorts and individual patients. Author summary Linking the features of tumors to a prognosis for the patient is a critical part of managing cancer. Many methods have been applied to this problem but we still lack accurate prognostic markers for many cancers. We now have more information than ever before on the state of the cancer genome, the epigenetic changes in tumors, and gene expression at both RNA and protein levels. Here, we address the question of how this data can be used to predict cancer survival and discover which tumor genes make the greatest contribution to the prognosis in individual tumor samples. We have developed a computational model, DeepMOCCA, that uses artificial neural networks underpinned by a large graph constructed from background knowledge concerning the functional interactions between genes and their products. We show that with our method, DeepMOCCA can predict cancer survival time based entirely on features of the tumor at a cellular and molecular level. The method confirms many existing genes that affect survival but for some cancers suggests new genes, either not implicated in survival before or not known to be important in that particular cancer. The ability to predict the important features in individual tumors provided by our method raises the possibility of personalized therapy based on the gene or network dominating the prognosis for that patient.

A multi-view multi-omics model for cancer drug response prediction

The prediction of drug sensitivity by multi-omics fusion reveals the heterogeneity of drug response in pan-cancer

MCMVDRP: a multi-channel multi-view deep learning framework for cancer drug response prediction

Deep learning and multi-omics approach to predict drug responses in cancer

XMR: an explainable multimodal neural network for drug response prediction

Drug Sensitivity Prediction Based on Multi-stage Multi-modal Drug Representation Learning

Multi-output prediction of dose-response curves enables drug repositioning and biomarker discovery

An Innovative Multi-Omics Model Integrating Latent Alignment and Attention Mechanism for Drug Response Prediction

MMCL-CDR: enhancing cancer drug response prediction with multi-omics and morphology images contrastive representation learning

Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data

Pancancer survival prediction using a deep learning architecture with multimodal representation and integration

Drug Response Modeling across Cancers: Proteomics vs. Transcriptomics

Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer

Circumventing Drug Resistance in Gastric Cancer: A Spatial Multi-omics Exploration of Chemo and Immuno-Therapeutic Response Dynamics

Prediction of Drug Response in Multilayer Networks Based on Fusion of Multiomics Data.

DeepMOCCA: A pan-cancer prognostic model identifies personalized prognostic markers through graph attention and multi-omics data integration

Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study

Predicting Drug Response Based on Multi-Omics Fusion and Graph Convolution

Multi-relational Multi-View Clustering and Its Applications in Cancer Subtype Identification

Interpretable Drug Response Prediction through Molecule Structure-aware and Knowledge-Guided Visible Neural Network

Multi-Omics Analysis for Improved Diagnosis, Prognosis, and Drug Response Prediction in Digestive System Tumors